World-first partial heart transplant with 'living tissue' saves baby boy born with fused arteries
Owen Monroe, from North Carolina, was born with his two main arteries fused together. Doctors used living tissue to seprate them and replace heart valves, which will grow with the infant. (Source: the Mail online | Health)
Source: the Mail online | Health - September 12, 2022 Category: Consumer Health News Source Type: news

TAVR Devices Keep Changing -- Is This Really Helping Patients?
(MedPage Today) -- CHICAGO -- Tweaks made to Medtronic's CoreValve transcatheter heart valve (THV) line in the last few years have tracked with some improved outcomes after transcatheter aortic valve replacement (TAVR), but it's still not clear... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 10, 2022 Category: Cardiology Source Type: news

Late-Breaking Data Reinforce Broad Range of Patients Benefit from Abbott's Mitral and Tricuspid Heart Valve Devices
MitraClip, manufactured by Abbott Abbott today announced late-breaking data for MitraClip ™, the world's first transcatheter edge-to-edge repair (TEER) device, and TriClip™, a first-of-its kind minimally invasive tricuspid heart valve repair device. The data reinforce the capabilities of the company's structural heart solutions for both mitral and tricuspid regurgitation (MR and TR) across a broad range of patient groups battling leaky heart valves (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - June 8, 2022 Category: Cardiology Source Type: news

Late-Breaking Data Reinforce Broad Range of Patients Benefit from Abbott's Mitral and Tricuspid Heart Valve Devices
- New results demonstrate MitraClip ™ transcatheter edge-to-edge repair (TEER) is effective at treating leaky valves in people with secondary mitral regurgitation (MR) (Source: Abbott.com)
Source: Abbott.com - June 8, 2022 Category: Pharmaceuticals Source Type: news

Patients with mitral annulus calcification at higher risk of heart valve and cardiovascular disease, Mayo Clinic research finds
ROCHESTER, Minn. — A retrospective review of more than 24,000 patients who underwent an echocardiogram at Mayo Clinic finds that nearly one-quarter of the patients had mitral annulus calcification, a chronic degeneration of tissue at the base of the heart's mitral valve. Mitral valve dysfunction was more than twic e as prevalent for those patients, who also were at higher risk of all-cause mortality. Mitral annulus calcification has been associated with cardiovascular diseases and events, as… (Source: Mayo Clinic Arizona News)
Source: Mayo Clinic Arizona News - June 1, 2022 Category: Hospital Management Source Type: news

Royal Papworth Hospital AI study could detect early heart valve disease
A database loaded with the sounds of heartbeats could help early detection of valve disease. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 24, 2022 Category: Consumer Health News Source Type: news

New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition (DPI) with XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD)
RARITAN, N.J., May 23, 2022 – Findings from the XARELTO® (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and the XARELTO® in Combination with Acetylsalicylic Acid (XATOA) registry have been published in the European Society of Cardiology’s (ESC) European Heart Journal, Cardiovascular Pharmacotherapy. Additionally, the XATOA registry was presented at the American Congress of Cardiology’s 71st Annual Scientific Session (ACC.22). These studies provide further evidence supporting the role of dual pathway inhibition (DPI) with the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 100 mg...
Source: Johnson and Johnson - May 23, 2022 Category: Pharmaceuticals Source Type: news

Scientists devise method to prevent deadly hospital infections without antibiotics
A hospital or medical clinic might be the last place you ’d expect to pick up a nasty infection, but approximately 1.7 million Americans do each year, resulting in nearly 100,000 deaths from infection-related complications and roughly $30 billion in direct medical costs.The biggest culprits, experts say — accounting for two-thirds of these infections — are medical devices like catheters, stents, heart valves and pacemakers, whose surfaces often become covered with harmful bacterial films. But a novel surface treatment developed by a UCLA-led team of scientists could help improve the safety of t hese devices and ease ...
Source: UCLA Newsroom: Health Sciences - May 19, 2022 Category: Universities & Medical Training Source Type: news

The keyhole heart valve op being denied to 40,000 patients
Only 7,000 transcatheter aortic valve implantation (TAVI) procedures take place each year, according to NHS data. (Left: John Morrison, of Co. Armagh, died aged 69 after waiting two years for a TAVI.) (Source: the Mail online | Health)
Source: the Mail online | Health - April 30, 2022 Category: Consumer Health News Source Type: news

AHA News: Despite Hopes, Vitamin K2 Supplements Fail to Slow Calcium Buildup in Heart Valve
Title: AHA News: Despite Hopes, Vitamin K2 Supplements Fail to Slow Calcium Buildup in Heart ValveCategory: Health NewsCreated: 4/25/2022 12:00:00 AMLast Editorial Review: 4/26/2022 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - April 26, 2022 Category: Cardiology Source Type: news

Data from New VOYAGER PAD Analyses at ACC.22 Reinforce Benefit of XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Peripheral Artery Disease (PAD) and Various Co-Morbid Conditions
RARITAN, N.J., April 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) in reducing severe vascular events in patients with PAD after lower-extremity revascularization (LER), a procedure that restores blood flow to the legs. Data from the two analyses demonstrate the role that the XARELTO® vascular dose plays in PAD patients with and without chronic kidney disease (CKD) and in PAD patients with and ...
Source: Johnson and Johnson - April 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

UA Gets $437K Grant to Study COVID's Effect on Heart Valve
Associate professor Kartik Balachandran will examine the role of a enzyme known as ACE2 in the infection process. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - March 25, 2022 Category: American Health Source Type: news

New Heart Valve in a Day? COVID-Fueled Studies Bolster the Case New Heart Valve in a Day? COVID-Fueled Studies Bolster the Case
Many patients already go home the day after transcatheter aortic valve replacement, but it ' s early days for same-day discharge procedures.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 24, 2022 Category: Cardiology Tags: Cardiology News Source Type: news

AHA News: A Routine Checkup Led Him to Fix a Leaky Heart Valve Before It Became a Problem
Title: AHA News: A Routine Checkup Led Him to Fix a Leaky Heart Valve Before It Became a ProblemCategory: Health NewsCreated: 3/16/2022 12:00:00 AMLast Editorial Review: 3/16/2022 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - March 16, 2022 Category: Cardiology Source Type: news

Man Who Got First Pig Heart Transplant Dies After Two Months
The first person to receive a heart transplant from a pig has died, two months after the groundbreaking experiment, the Maryland hospital that performed the surgery announced Wednesday. David Bennett, 57, died Tuesday at the University of Maryland Medical Center. Doctors didn’t give an exact cause of death, saying only that his condition had begun deteriorating several days earlier. Bennett’s son praised the hospital for offering the last-ditch experiment, saying the family hoped it would help further efforts to end the organ shortage. “We are grateful for every innovative moment, every crazy dream, every...
Source: TIME: Health - March 9, 2022 Category: Consumer Health News Authors: LAURAN NEERGAARD and CARLA K. JOHNSON / AP Tags: Uncategorized healthscienceclimate medicine News Desk wire Source Type: news